Health Policy · 7 min
Medicare's Prescription Subsidy Cut: Your Premiums Are About to Climb
The Trump administration's move to end a key federal payment for Part D plans in 2027 will likely mean higher out-of-pocket costs for millions of seniors.
The Palmelle Archive
Every Perch story, ranked by date. Plain-English reporting on the second half of life. 23 stories indexed.
Health Policy · 7 min
The Trump administration's move to end a key federal payment for Part D plans in 2027 will likely mean higher out-of-pocket costs for millions of seniors.
Health Policy · 7 min
While hailed as improvements, new House proposals may mask deeper issues impacting seniors' long-term access to care.
Health Policy · 7 min
As a key Medicare drug subsidy program ends, seniors face uncertain prescription costs.
Health Policy · 7 min
A voluntary program designed to cushion prescription drug premium volatility is being phased out, potentially leaving fixed-income beneficiaries to shoulder une
Health Policy · 7 min
After years of agonizing delays, a bipartisan House committee vote signals a major win for seniors seeking timely medical care.
Health Policy · 7 min
Forget the headlines about rising costs; a new CMS proposal quietly aims to lower out-of-pocket expenses for seniors in specific care models, but the devil is i
Health Policy · 7 min
A new CMS regulation targeting how states fund Medicaid could slash vital services for seniors and low-income families, despite official claims of 'oversight.'
Health Policy · 7 min
Mainstream coverage missed the point: new Medicare Advantage rules for 2027 could hit seniors' wallets and access, especially in rural areas.
Health Policy · 7 min
CMS proposes 2027 reforms, promising value-based care while boosting Medicare Advantage payments.
Health Policy · 7 min
Mainstream coverage overlooks how federal actions will make it easier for states to reduce home and community-based care, potentially forcing more seniors into
Health Policy · 7 min
Forget the narrative that cutting-edge medications are out of reach. A new CMS program offers a predictable, affordable path to vital treatments for eligible se
Health Policy · 7 min
New rules boost insurer payments while quietly rolling back crucial consumer protections, especially around marketing.
Health Policy · 7 min
As drug price negotiations loom, industry spending skyrockets, directly impacting what seniors pay at the pharmacy counter.
Health Policy · 7 min
New rules aim to curb fraud and boost access, a welcome shift from budget-cut narratives.
Health Policy · 7 min
The CMS GLP-1 Bridge program offers seniors a taste of costly medications, but the real story is about market shifts and what's coming next.
Health Policy · 7 min
CMS boosts payments but rolls back marketing guardrails, creating a mixed bag for seniors.
Health Policy · 7 min
Proposed cuts threaten the lifeline for millions of seniors and disabled Americans, painting a stark picture of fiscal priorities.
Health Policy · 7 min
A closer look at Medicare Advantage plans reveals a disturbing pattern of denying medically necessary care, contradicting promises of enhanced benefits for seni
Health Policy · 7 min
Mainstream headlines miss the disproportionate impact of proposed federal budget cuts on older adults, particularly those in ACA expansion states.
Health Policy · 7 min
CMS cracks down on insurer tactics and boosts prescription drug help, but vigilance remains key.
Health Policy · 7 min
The mainstream media missed the real victims of the Inflation Reduction Act's big pharma negotiation plan: seniors in long-term care.
Health Policy · 7 min
Mainstream media misses how new rules disproportionately impact older, vulnerable Americans, not just younger ones.
Health Policy · 7 min
The promise of extra benefits crumbles as insurers retreat, leaving beneficiaries scrambling for stable healthcare.